CS-747S PhaseIII trial (elective PCI)
Phase 3
- Conditions
- CAD patients who are to undergo elective PCI
- Registration Number
- JPRN-jRCT2080221511
- Lead Sponsor
- DAIICHISANKYO Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
Subjects aged 20 or above when written informed consent were signed by the subjects.
-CAD patients with coronary artery stenosis identified by coronary angiography or CT scan, and scheduled for elective PCI.
Exclusion Criteria
-High bleeding risk
-Subjects with ACS
-Liver and/or kidney function impairment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method